Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20): retrospective cohort study

OBJECTIVE: To analyze the therapeutic value of supplemental indications compared with first indications for drugs approved in the US and Europe. DESIGN: Retrospective cohort study. SETTING: New and supplemental indications approved by the US Food and Drug Administration (FDA) and European Medicines...

Descripción completa

Detalles Bibliográficos
Autores principales: Vokinger, Kerstin N, Glaus, Camille E G, Kesselheim, Aaron S, Serra-Burriel, Miquel, Ross, Joseph S, Hwang, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320829/
https://www.ncbi.nlm.nih.gov/pubmed/37407074
http://dx.doi.org/10.1136/bmj-2022-074166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320829/
https://www.ncbi.nlm.nih.gov/pubmed/37407074
http://dx.doi.org/10.1136/bmj-2022-074166

Ejemplares similares